- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06719258
Evaluering av gassfuktingspraksis hos pasienter under invasiv mekanisk ventilasjon (FP950)
Evaluering av gassfuktingspraksis hos pasienter under invasiv mekanisk ventilasjon: Fordeler med F & P950 oppvarmet luftfukter: Sammenligning med MR 850 om kliniske hendelser med underfukting
When mechanical ventilation is initiated, a humidification method should be chosen. There is two methods: heat and humidity exchanger filters or heated humidity. The second method is recognized to be more efficient, but many external factors can influence its performance. Insufficient humidity results in observable problems, such as difficult management of respiratory secretions.
The study compare two heated humidifiers already used in ICU.
Data will be collected retrospectively from June 1, 2021.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiesteder
-
-
Quebec
-
Québec, Quebec, Canada, G1V4G5
- Institut Universitaire de Cardiologie et de Pneumologie de Québec
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
All patient in ICU on ventilation will be consider.
Beskrivelse
Inclusion Criteria:
- ≥ 18 years old
- Admitted to intensive care
- Under invasive mechanical ventilation with the usual indications for the use of a heated humidifier (prolonged invasive mechanical ventilation and / or protective ventilation requiring high respiratory rates.
Exclusion Criteria:
- Mechanical venitilation immediately after surgery (<24h)
- Imminent extubation or planned intubation of very short duration (<24h)
- Enrolled in the SAVE-ICU study in the group receiving volatile agents with the AnaConDa system.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: RETROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
MR850
20 subjects on this heating humidifier (Fisher & Paykel MR850). |
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours. |
|
FP950
20 subjects on this heating humidifier (Fisher & Paykel FP950). |
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Endotracheal tube occlusion requiring emergency tube change
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of endotracheal tube occlusion requiring emergency tube change |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Bronchoscopy
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of performing a bronchoscopy for a suspected sub-occlusion (thick or sticky secretions), and the total number of bronchoscopies performed per patient |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Tracheal saline instillations
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of tracheal saline instillations due to sticky secretions or suspected endotracheal tube sub-occlusion |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Thick secretions
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - Occurence of tracheal secretions describe at thick secretions (rated at 5 on the secretions scale used at the hospital) or "sticky secretions" if specified |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
|
Change humidifier settings
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Under-humidification episodes are defined as follows: - The number of operations required to change humidifier settings if the plate temperature is below 62 degrees Celcius (with the MR850). |
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Other elements that may be influenced by the quality of the humidification used during mechanical ventilation
Tidsramme: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
These data will be collected:
|
At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2022-3714
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .